KindredBio to Sponsor 1.40m Class and Big Bonuses at HITS Coachella 

 

Saugerties, NY (January 21, 2017): HITS, Inc. is pleased to announce that it’s highly-valued Platinum Sponsor, Kindred Biosciences Inc., has signed on as the title sponsor of the 1.40 meter jumper class during the 2017 HITS Coachella Desert Circuit in Thermal, California. KindredBio will also offer the KindredBio Leading Rider, an honor that will be calculated by a point system similar to the calculation of the Longines FEI World Cup™ Jumping Standings. The rider awarded will receive a perpetual trophy and a $1,000 rider’s bonus. 

“Last year marked KindredBio’s first sponsorship in the industry and we are very proud to have them back on the team this year,” said HITS President and CEO Tom Struzzieri. “The KindredBio Leading Rider Award is a fantastic addition to the circuit— we aim to provide the best possible experience to our clients, and sponsors like KindredBio, are essential in helping us achieve these goals.”  

The 1.40m class is a popular class for riders of different ages and levels. From amateur riders hoping to advance their skills, to professionals taking horses in the class to gain experience, the class provides great competition throughout the circuit.

Co-Founder and COO of KindredBio, Denise Bevers explains, “Given the level of athleticism in the 1.40m class, we are excited to offer the KindredBio Leading Rider trophy and bonus to the rider who excels throughout the circuit.  We look forward to seeing who ends up on top!”

Olympic gold medalist, McLain Ward, complimented the KindredBio Jumper Classic at the 2016 Saugerties Summer Series.

“Classes like these are a nice outlet for horses and growing riders to compete in a solid class, that’s not as big as the Grand Prix, but a good class,” said Ward. “It’s great to have their support in our sport. A lot of care goes into these horses, and companies that provide a veterinary service to keep these animals competing and healthy are important.”

 About Kindred Biosciences 
Kindred Biosciences is a development-stage biopharmaceutical company focused on saving and improving the lives of pets.  Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy.  The Company’s strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for dogs, cats, and horses.  The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes. 

At KindredBio we believe that our equine family members are just as important as our companion animals.  We have a strong pipeline with novel drugs and biologics in development that are made to meet the needs of the horse, the owner, the trainer, and the veterinarian. We are horse people and we share the love of the horse with our customers.

For more information or to download the corporate presentation, visit www.KindredBio.com. Stay connected with KindredBio on Facebook at www.Facebook.com/KindredBio.